AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.8 Out of 5 (5241 Reviews)

Mutual fund investing with KSquare has been fantastic. I appreciate their attention to risk profiling and how they tailor recommendations. It’s an empowering experience.

Kavya Iyer

Kavya Iyer

Biotech Researcher

I never thought mutual fund investing could be this simple. KSquare helps me manage risk and meet financial targets effortlessly. Great for working women like me.

Neha Bajaj

Neha Bajaj

Human Resource Lead

I feel empowered thanks to KSquare. Their NRI Corner is well-structured, and the financial advice is incredibly relevant and actionable.

Sanya Roy

Sanya Roy

NGO Director

Starting my SIP journey with KSquare was the best decision. Their platform is intuitive, and I feel secure knowing my money is growing steadily.

Tanya Arora

Tanya Arora

Teacher

I was amazed by how quickly KSquare approved my loan. The entire system felt modern and very intuitive.

Tanya Deshmukh

Tanya Deshmukh

Clinical Therapist

KSquare made the loan process so efficient that I didn’t feel stressed at all. Fantastic customer support as well.

Riya Bhattacharya

Riya Bhattacharya

Brand Consultant

I always wanted to invest in mutual funds but felt overwhelmed. KSquare made everything so simple. Their expert suggestions helped me start confidently and stay informed.

Ishita Malhotra

Ishita Malhotra

Digital Illustrator

Thanks to KSquare, I can now invest in India confidently from the US. Their team was extremely helpful and always available when I had questions.

Varun Iyer

Varun Iyer

Finance Manager

KSquare presents each new fund launch with such clarity. Their tools gave me better understanding of sectors and fund outlooks before investing.

Harsh Vardhan

Harsh Vardhan

Energy Analyst

I appreciate the balance of automation and control KSquare gives. Their fund research and regular updates give me confidence in every investment decision I make.

Mayank Verma

Mayank Verma

Business Analyst

FAQ's

Frequenlty Asked Question

What is a Systematic Investment Plan (SIP)?

A SIP is a disciplined investment method where you invest a fixed amount regularly in mutual funds to build wealth over time.

How are NFO units allotted after subscription closes?

After the subscription period, units are allotted based on the face value and investment amount on the allotment date.

How do I track my NPS account with KSquare?

You can log in to your KSquare dashboard to see real-time NAVs, contributions, and returns from your NPS account.

Can I nominate someone in India for my investments?

Yes, NRIs can nominate any Indian resident for their mutual fund holdings and other financial assets via KSquare.

Why should I choose KSquare for my SIP needs?

KSquare offers expert support, real-time tracking, flexible options, and a user-friendly platform to grow your wealth steadily.

How do I track the performance of an NFO after investment?

Once listed, KSquare provides regular updates and performance tracking via your investor dashboard.

Can NRIs invest in NPS through KSquare?

Yes, NRIs can invest in NPS if they meet KYC norms. KSquare supports NRI onboarding for NPS accounts.

Can I start SIPs with a small monthly amount?

Yes, KSquare allows flexible SIP amounts, enabling anyone to start small and gradually increase investments based on comfort

App Store